These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The use of citrulline for the treatment of Reye's syndrome: case reports. Oetgen WJ Mil Med; 1977 Feb; 142(2):162-4. PubMed ID: 401969 [No Abstract] [Full Text] [Related]
24. Evidence for the involvement of the benzodiazepine receptor complex in hepatic encephalopathy. Implications for treatment with benzodiazepine receptor antagonists. Basile AS; Gammal SH Clin Neuropharmacol; 1988 Oct; 11(5):401-22. PubMed ID: 2905934 [No Abstract] [Full Text] [Related]
30. Hepatic metabolic alterations in rats treated with low-dose endotoxin and aspirin: an animal model of Reye's syndrome. Kilpatrick LE; Polin RA; Douglas SD; Corkey BE Metabolism; 1989 Jan; 38(1):73-7. PubMed ID: 2909830 [TBL] [Abstract][Full Text] [Related]
31. Modulation of the GABAergic tone by benzodiazepine receptor ligands in chronic hepatic encephalopathy in the dog. Meyer HP; Rothuizen J Vet Q; 1998; 20 Suppl 1():S100-1. PubMed ID: 9652036 [No Abstract] [Full Text] [Related]
32. Free fatty acids in an animal model of Reye's syndrome. Deshmukh DR; Deshmukh GD; Shope TC; Radin NS Biochim Biophys Acta; 1983 Sep; 753(2):153-8. PubMed ID: 6615853 [TBL] [Abstract][Full Text] [Related]
33. Letter: Citrulline for Reye's syndrome. DeLong GR; Glick TH; Shannon DC N Engl J Med; 1974 Jun; 290(26):1488. PubMed ID: 4831769 [No Abstract] [Full Text] [Related]
34. Reye's syndrome in nonpediatric age groups. Varma RR; Riedel DR; Komorowski RA; Harrington GJ; Nowak TV JAMA; 1979 Sep; 242(13):1373-5. PubMed ID: 480558 [TBL] [Abstract][Full Text] [Related]
35. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist]. Janicki P; Rewerski W Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1653-6. PubMed ID: 2855862 [No Abstract] [Full Text] [Related]
36. [Reye's (or Reye-like) syndrome (encephalopathy and small droplet fatty liver) in adults. Polyetiologic or drug induced?]. Martini GA Internist (Berl); 1981 Sep; 22(9):578-82. PubMed ID: 7028673 [No Abstract] [Full Text] [Related]
37. [Acute hepatic encephalopathy (Reye's syndrome) in children)]. Berestov AI; Blokhin BM; Zharov AP; Zhilina SS Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(8):29-32. PubMed ID: 3195278 [TBL] [Abstract][Full Text] [Related]
38. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850 [TBL] [Abstract][Full Text] [Related]
39. [Acute encephalopathy associated with centrilobular necrosis of liver mimicking Reye's syndrome--report of two cases]. Lii YP; Chi SC; Mak SC Zhonghua Yi Xue Za Zhi (Taipei); 1993 Feb; 51(2):154-7. PubMed ID: 8385558 [TBL] [Abstract][Full Text] [Related]
40. Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity. Abdin A; Sarhan N Can J Physiol Pharmacol; 2014 Sep; 92(9):780-8. PubMed ID: 25162205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]